Figure 1.

Organoid models of liver cancer. Broutier et al.5 generated tumor organoids, termed tumoroids, from liver cancer tumor biopsies spanning a range of histological types. Screening of these organoids identified a small-molecule ERK1/2 inhibitor as a potential liver cancer therapeutic and also identified potential prognostic biomarkers.